Strategic Diagnostics (SDIX) trading halted with news pending
- Asia stocks rise, yen plumbs 34-year low as BOJ stands pat on rates
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock soars 12% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Strategic Diagnostics (SDIX) Will Resume Trading at 9:45am ET
April 8, 2013 9:23 AM EDTStrategic Diagnostics, Inc. (NASDAQ: SDIX) to resume trading at 9:45am EDT.... More
SDIX (SDIX) to Sell Life Science Assets in $16M Deal
April 8, 2013 9:06 AM EDTSDIX (Nadaq: SDIX) announced that it has entered into an agreement to sell the assets of its Life Science business to OriGene Technologies, Inc. for $16 million. OriGene is acquiring substantially all of the assets of SDIX and has agreed to offer employment to a... More